SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001411685-24-000037
Filing Date
2024-08-13
Accepted
2024-08-13 16:49:59
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtgn-20240630.htm   iXBRL 10-Q 1098397
2 EX-31.1 vtgn-20231231xexx311.htm EX-31.1 10132
3 EX-31.2 vtgn-20231231xexx312.htm EX-31.2 10058
4 EX-32 vtgn-20231231xexx32.htm EX-32 5228
  Complete submission text file 0001411685-24-000037.txt   4679082

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtgn-20240630.xsd EX-101.SCH 33780
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtgn-20240630_cal.xml EX-101.CAL 36869
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtgn-20240630_def.xml EX-101.DEF 129602
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtgn-20240630_lab.xml EX-101.LAB 484516
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtgn-20240630_pre.xml EX-101.PRE 310960
60 EXTRACTED XBRL INSTANCE DOCUMENT vtgn-20240630_htm.xml XML 386154
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 241202507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)